Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Price to Sales HistoryFair Value
Percentile Rank14
3Y CAGR-3.9%
5Y CAGR-1.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-3.9%/yr
vs -0.2%/yr prior
5Y CAGR
-1.7%/yr
Consistent
Acceleration
-3.8pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.63 | +4.0% |
| 2024 | 5.41 | -24.2% |
| 2023 | 7.14 | +12.5% |
| 2022 | 6.35 | +52.8% |
| 2021 | 4.15 | -32.1% |
| 2020 | 6.12 | -2.2% |
| 2019 | 6.25 | -2.1% |
| 2018 | 6.39 | -13.9% |
| 2017 | 7.42 | -15.5% |
| 2016 | 8.78 | - |